Cargando…

High prevalence of coronavirus NL63 in SARS-CoV-2 negative COVID-19 suspected patients

Detalles Bibliográficos
Autores principales:	Sadidi, Roya, Azimian, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249365/ https://www.ncbi.nlm.nih.gov/pubmed/37305023 http://dx.doi.org/10.1016/j.nmni.2023.101159

Ejemplares similares

Stability of human metapneumovirus and human coronavirus NL63 on medical instruments and in the patient environment
por: Müller, A., et al.
Publicado: (2008)

Atypical HCoV-NL63 Infection in an Infant During the SARS-CoV-2 Pandemic
por: Domouzoglou, Eleni M., et al.
Publicado: (2020)

Understanding Human Coronavirus HCoV-NL63
por: Abdul-Rasool, Sahar, et al.
Publicado: (2010)

Human Coronavirus NL63, France
por: Vabret, Astrid, et al.
Publicado: (2005)

Attachment Factor and Receptor Engagement of Sars Coronavirus and Human Coronavirus NL63
por: Hofmann, Heike, et al.
Publicado: (2006)

Croup Is Associated with the Novel Coronavirus NL63
por: van der Hoek, Lia, et al.
Publicado: (2005)

The Nucleocapsid Protein of Human Coronavirus NL63
por: Zuwała, Kaja, et al.
Publicado: (2015)

Stability of infectious human coronavirus NL63
por: Florek, Dominik, et al.
Publicado: (2014)

Nonstructural Proteins of Human Coronavirus NL63
por: Piotrowski, Yvonne, et al.
Publicado: (2006)

Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses
por: Wondrak, Georg T., et al.
Publicado: (2021)

Solar simulated ultraviolet radiation inactivates HCoV-NL63 and SARS-CoV-2 coronaviruses at environmentally relevant doses
por: Wondrak, Georg T., et al.
Publicado: (2021)

SARS-CoV, But not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entry
por: Huang, I-Chueh, et al.
Publicado: (2006)

Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
por: Carbajo-Lozoya, Javier, et al.
Publicado: (2012)

Human Coronavirus NL63 Infection is Associated with Croup
por: Stang, Alexander, et al.
Publicado: (2006)

Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63
por: Saletti, Giulietta, et al.
Publicado: (2020)

Genome structure and transcriptional regulation of human coronavirus NL63
por: Pyrc, Krzysztof, et al.
Publicado: (2004)

Phylogenetic analysis of human coronavirus NL63 circulating in Italy
por: Minosse, C., et al.
Publicado: (2008)

Identification of cell lines permissive for human coronavirus NL63
por: Schildgen, Oliver, et al.
Publicado: (2006)

Human coronavirus NL63: a clinically important virus?
por: Fielding, Burtram C
Publicado: (2011)

Molecular mechanisms of human coronavirus NL63 infection and replication
por: Castillo, Gino, et al.
Publicado: (2023)

Response to “Emphysematous cholecystitis in suspected SARS-CoV-2 infection”()
por: Gómez Sánchez, Javier, et al.
Publicado: (2021)

Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro
por: Stone, Nathan E., et al.
Publicado: (2021)

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia
por: Lynch, Sean A., et al.
Publicado: (2021)

Seroconversion to HCoV-NL63 in Rhesus Macaques
por: Dijkman, Ronald, et al.
Publicado: (2009)

Novel polymeric inhibitors of HCoV-NL63
por: Milewska, Aleksandra, et al.
Publicado: (2013)

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

Catalytic function and substrate specificity of alpha and beta coronavirus papain-like proteases: targeting human NL63, SARS-CoV and SARS-CoV-2 (Covid-19) with designed inhibitors
por: Chapman, Mackenzie E., et al.
Publicado: (2022)

Severe Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care Facility
por: Hand, Julie, et al.
Publicado: (2018)

SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells
por: Huang, I-Chueh, et al.
Publicado: (2006)

Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye
por: Al-Sharif, Eman, et al.
Publicado: (2020)

Human Coronavirus-NL63 Infection is not Associated with Acute Kawasaki Disease
por: Baker, S. C., et al.
Publicado: (2006)

The dominance of human coronavirus OC43 and NL63 infections in infants
por: Dijkman, Ronald, et al.
Publicado: (2012)

Human Coronavirus-NL63 infections in Korean children, 2004–2006
por: Han, Tae Hee, et al.
Publicado: (2007)

Clinical manifestations of human coronavirus NL63 infection in children in Taiwan
por: Wu, Ping-Sheng, et al.
Publicado: (2007)

Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2
por: Nawrath, Philipp, et al.
Publicado: (2022)

Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2
por: Lan, Jun, et al.
Publicado: (2022)

Membrane Protein of Human Coronavirus NL63 Is Responsible for Interaction with the Adhesion Receptor
por: Naskalska, Antonina, et al.
Publicado: (2019)

Crystal Structure of Human Coronavirus NL63 Main Protease in Complex With an Inhibitor
por: Yang, Kailin, et al.
Publicado: (2015)

Burden of disease due to human coronavirus NL63 infections and periodicity of infection
por: van der Hoek, Lia, et al.
Publicado: (2010)

Mosaic Structure of Human Coronavirus NL63, One Thousand Years of Evolution
por: Pyrc, Krzysztof, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9bgljldc66ol8rl16c8n8ok6ke